{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT03837756: Phase 2 Interventional Completed HIV-1-infection
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04706741: Phase 2 Interventional Completed Uveitis
(2022)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04699630: Phase 2 Interventional Active, not recruiting Metastatic Breast Cancer
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03071341: Phase 1/Phase 2 Interventional Completed Mucopolysaccharidosis I
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02583165: Phase 1 Interventional Completed Advanced Solid Tumors
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04386616: Phase 2 Interventional Completed COVID-19 Pneumonia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03586830: Phase 2 Interventional Completed Obesity and Diabetes Mellitus, Type 2
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:lenvervimab [INN]
Source URL:
Class:
PROTEIN
